CN113189342B - 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒 - Google Patents

鉴定、评估、预防以及治疗肺疾病的方法及试剂盒 Download PDF

Info

Publication number
CN113189342B
CN113189342B CN202110251315.3A CN202110251315A CN113189342B CN 113189342 B CN113189342 B CN 113189342B CN 202110251315 A CN202110251315 A CN 202110251315A CN 113189342 B CN113189342 B CN 113189342B
Authority
CN
China
Prior art keywords
biomarkers
leu
ser
biomarker
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110251315.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN113189342A (zh
Inventor
R·T·斯特里佩
E·伊兹比卡
S·H·贝克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Prevention and Cure Ltd
Original Assignee
Cancer Prevention and Cure Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/403,369 external-priority patent/US8541183B2/en
Application filed by Cancer Prevention and Cure Ltd filed Critical Cancer Prevention and Cure Ltd
Priority to CN202110251315.3A priority Critical patent/CN113189342B/zh
Publication of CN113189342A publication Critical patent/CN113189342A/zh
Application granted granted Critical
Publication of CN113189342B publication Critical patent/CN113189342B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202110251315.3A 2009-03-12 2010-03-12 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒 Active CN113189342B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110251315.3A CN113189342B (zh) 2009-03-12 2010-03-12 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US12/403,369 2009-03-12
US12/403,369 US8541183B2 (en) 2007-09-11 2009-03-12 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
US23719809P 2009-08-26 2009-08-26
US61/237,198 2009-08-26
PCT/US2010/027243 WO2010105235A2 (en) 2009-03-12 2010-03-12 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
CN2010800172205A CN102405296A (zh) 2009-03-12 2010-03-12 包括基于性别的疾病鉴定、评估、预防以及治疗的用于肺疾病的鉴定、评估、预防以及治疗的方法及其试剂盒
CN202110251315.3A CN113189342B (zh) 2009-03-12 2010-03-12 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2010800172205A Division CN102405296A (zh) 2009-03-12 2010-03-12 包括基于性别的疾病鉴定、评估、预防以及治疗的用于肺疾病的鉴定、评估、预防以及治疗的方法及其试剂盒

Publications (2)

Publication Number Publication Date
CN113189342A CN113189342A (zh) 2021-07-30
CN113189342B true CN113189342B (zh) 2024-12-03

Family

ID=42729154

Family Applications (4)

Application Number Title Priority Date Filing Date
CN201810113758.4A Active CN108181457B (zh) 2009-03-12 2010-03-12 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒
CN201410593458.2A Pending CN104535765A (zh) 2009-03-12 2010-03-12 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒
CN202110251315.3A Active CN113189342B (zh) 2009-03-12 2010-03-12 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒
CN2010800172205A Pending CN102405296A (zh) 2009-03-12 2010-03-12 包括基于性别的疾病鉴定、评估、预防以及治疗的用于肺疾病的鉴定、评估、预防以及治疗的方法及其试剂盒

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CN201810113758.4A Active CN108181457B (zh) 2009-03-12 2010-03-12 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒
CN201410593458.2A Pending CN104535765A (zh) 2009-03-12 2010-03-12 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2010800172205A Pending CN102405296A (zh) 2009-03-12 2010-03-12 包括基于性别的疾病鉴定、评估、预防以及治疗的用于肺疾病的鉴定、评估、预防以及治疗的方法及其试剂盒

Country Status (10)

Country Link
US (1) US11474104B2 (enExample)
EP (4) EP3257953B1 (enExample)
JP (7) JP2012520469A (enExample)
KR (2) KR101900016B1 (enExample)
CN (4) CN108181457B (enExample)
AU (3) AU2010223911A1 (enExample)
CA (2) CA2755301C (enExample)
ES (1) ES2703714T3 (enExample)
PL (1) PL3257953T3 (enExample)
WO (1) WO2010105235A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3851856A3 (en) 2007-03-27 2021-11-03 Immunovia AB Method, array and use thereof
CA3290895A1 (en) 2011-04-29 2025-11-29 Lung Cancer Proteomics Llc Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
JP2018532992A (ja) * 2015-09-09 2018-11-08 ソマロジック, インコーポレイテッドSomaLogic, Inc. 個別化薬物治療計画の開発方法、及びプロテオミックプロファイルに基づく標的薬物開発
KR102078310B1 (ko) * 2015-09-11 2020-02-19 주식회사 압타머사이언스 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN112501140B (zh) * 2020-12-16 2022-03-18 熊猫乳品集团股份有限公司 一种生物活性多肽yfgsgfaapffivrhqllkk及其制备方法和应用
TWI796010B (zh) * 2021-11-23 2023-03-11 國立高雄大學 基質金屬蛋白酶-1胜肽拓印導電聚合物及其用途
CN117907508A (zh) * 2023-12-19 2024-04-19 查理高特(青岛)健康科技有限公司 基于代谢组学的高尿酸血症及尿酸性肾病的风险预测系统

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE359515T1 (de) 1997-02-12 2007-05-15 Electrophoretics Ltd Proteinmarker für lungenkrebs und deren verwendung
US20070092917A1 (en) 1998-05-01 2007-04-26 Isabelle Guyon Biomarkers for screening, predicting, and monitoring prostate disease
US7115261B1 (en) 1999-02-12 2006-10-03 The Scripps Research Institute Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
IL144559A0 (en) 1999-03-01 2002-05-23 Genentech Inc Antibodies for cancer therapy and diagnosis
FI990888A0 (fi) * 1999-04-20 1999-04-20 Medix Biochemica Ab Oy Menetelmä ja testikittejä respiratorisen alueen tulehduksen läsnäolon ja vaikeusasteen arvioimiseksi
AU773832B2 (en) * 1999-04-26 2004-06-10 Ppd Biomarker Discovery Sciences, Llc Phenotype and biological marker identification system
EP1299530A4 (en) 2000-07-12 2005-03-09 Smithkline Beecham Corp NEW COMPOUNDS
JP2004526154A (ja) * 2001-03-12 2004-08-26 モノジェン インコーポレイテッド 細胞ベースの検出および病態の判別
US20030190602A1 (en) 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
DK1402073T3 (da) 2001-06-05 2007-06-11 Auckland Uniservices Ltd Fremgangsmåder og præparater til vurdering af lungefunktion og -lidelser
US20030134339A1 (en) 2002-01-14 2003-07-17 Thomas Brown Proteomics based method for toxicology testing
US20060088537A1 (en) 2002-04-11 2006-04-27 Terrett Jonathan A Protein involved in cancer
WO2004030511A2 (en) 2002-05-10 2004-04-15 Eastern Virginia Medical School Prostate cancer biomarkers
AU2003240495A1 (en) * 2002-06-04 2003-12-19 Incyte Corporation Diagnostics markers for lung cancer
CN1705753A (zh) * 2002-09-30 2005-12-07 肿瘤疗法科学股份有限公司 非小细胞肺癌的诊断方法
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
CA2833559A1 (en) 2003-02-14 2004-09-02 Children's Hospital & Research Center At Oakland Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions
EP1599587A2 (en) * 2003-03-04 2005-11-30 Wyeth Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
CN101265254A (zh) * 2003-03-27 2008-09-17 兰肯瑙医学研究所 新型ido抑制剂及其使用方法
JP2005044330A (ja) 2003-07-24 2005-02-17 Univ Of California San Diego 弱仮説生成装置及び方法、学習装置及び方法、検出装置及び方法、表情学習装置及び方法、表情認識装置及び方法、並びにロボット装置
JP4938451B2 (ja) * 2004-03-23 2012-05-23 オンコセラピー・サイエンス株式会社 非小細胞肺癌の診断のための方法
US20090204334A1 (en) 2004-03-30 2009-08-13 Eastern Virginia Medical School Lung cancer biomarkers
US20060154276A1 (en) 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
WO2006044946A2 (en) * 2004-10-20 2006-04-27 Onco Detectors International, Llc Migration inhibitory factor in serum as a tumor marker for prostate, bladder, breast, ovarian, kidney and lung cancer
US20090297563A1 (en) * 2004-10-27 2009-12-03 Anders Borglum Diagnosis And Treatment of Immune-Related Diseases
BRPI0518734A2 (pt) 2004-11-30 2008-12-02 Veridex Llc prognàstico de cÂncer de pulmço
CN1300580C (zh) 2004-12-31 2007-02-14 中国人民解放军第306医院 检测肝癌血清特征蛋白的质谱模型及其制备方法和应用
GB0508863D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Peptide
US20080044420A1 (en) 2005-05-11 2008-02-21 Heavner George A Anti-IL-13 antibodies, compositions, methods and uses
US20070099239A1 (en) 2005-06-24 2007-05-03 Raymond Tabibiazar Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
WO2007013671A2 (en) * 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
US7612181B2 (en) * 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
EP2500352A1 (en) * 2005-08-19 2012-09-19 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
JPWO2007026773A1 (ja) 2005-08-31 2009-03-12 学校法人 久留米大学 医用診断処理装置
US7955837B2 (en) 2005-10-29 2011-06-07 Bayer Technology Services Gmbh Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
US20080133141A1 (en) 2005-12-22 2008-06-05 Frost Stephen J Weighted Scoring Methods and Use Thereof in Screening
US9347945B2 (en) 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
KR100760518B1 (ko) 2006-07-18 2007-09-20 삼성정밀공업 주식회사 가구용 도어의 닫힘 충격 완충 장치
US7840505B2 (en) 2006-11-02 2010-11-23 George Mason Intellectual Properties, Inc. Classification tool
AU2007322206A1 (en) 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer
US8343491B2 (en) * 2006-12-18 2013-01-01 The Johns Hopkins University Anti-HIMF antibodies to treat lung diseases
JP5085927B2 (ja) 2006-12-21 2012-11-28 ウィンテックポリマー株式会社 難燃性樹脂組成物
WO2008106200A2 (en) * 2007-02-28 2008-09-04 Novimmune Sa Human anti-ip-10 antibodies and uses thereof
CA2679436C (en) 2007-04-05 2018-10-23 Aureon Laboratories, Inc. Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
US20100179067A1 (en) 2007-05-18 2010-07-15 Patz Jr Edward F Serum biomarkers for the early detection of lung cancer
US20100272635A1 (en) 2007-06-15 2010-10-28 Rodems Kelline M Methods and compositions for diagnosis and/or prognosis in ovarian cancer and lung cancer
US7888051B2 (en) * 2007-09-11 2011-02-15 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
PL2195645T3 (pl) 2007-09-11 2014-12-31 Cancer Prevention & Cure Ltd Metoda wspomagająca diagnostykę i terapię astmy i rak płuc
US8541183B2 (en) * 2007-09-11 2013-09-24 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
JP5159242B2 (ja) 2007-10-18 2013-03-06 キヤノン株式会社 診断支援装置、診断支援装置の制御方法、およびそのプログラム
JP5591711B2 (ja) 2007-12-10 2014-09-17 エフ．ホフマン−ラ ロシュ アーゲー 結腸直腸癌のためのマーカーパネル
CA2712303C (en) 2008-01-18 2015-03-31 President And Fellows Of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
CA2717763A1 (en) 2008-03-04 2009-09-11 John Bilello Diagnosing and monitoring depression disorders based on multiple biomarker panels
CN101587125B (zh) 2008-05-21 2013-07-24 林标扬 高表达癌症标记物和低表达组织器官标记物组合试剂盒
ES2559758T3 (es) 2008-09-09 2016-02-15 Somalogic, Inc. Biomarcadores de cáncer de pulmón y usos de los mismos
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CN101988059B (zh) 2009-07-30 2014-04-02 江苏命码生物科技有限公司 胃癌检测标记物及其检测试剂盒和生物芯片
KR20140024860A (ko) 2011-02-24 2014-03-03 버밀리언, 인코포레이티드 난소암에 대한 바이오마커 패널，진단 방법 및 시험 키트
CA3290895A1 (en) 2011-04-29 2025-11-29 Lung Cancer Proteomics Llc Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
WO2015066564A1 (en) 2013-10-31 2015-05-07 Cancer Prevention And Cure, Ltd. Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
US20170073763A1 (en) 2014-03-12 2017-03-16 The Board Of Trustees Of The Leland Stanford Junior University Methods and Compositions for Assessing Patients with Non-small Cell Lung Cancer

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ERCC1、MMP7和Livin在非小细胞肺癌组织中的表达及意义;李金凤;蒋捍东;;山东医药;20090206(第05期);40-41 *
The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC);Eleni M. Karapanagiotou 等;《Lung Cancer》;20081231;第61卷;391-397 *
肺癌患者外周血IL-2和IL-10水平检测的临床价值;陈恩国, 应可净, 洪武军, 赵晨;实用肿瘤杂志;20041025(第05期);420-422 *
血清基质金属蛋白酶-9等对非小细胞肺癌诊断的临床意义;刘晓芳;陈东宁;张沪生;;临床内科杂志;20060528(第05期);331-333 *
非小细胞肺癌患者血清中IL-8水平的研究及相关临床意义探讨;张妍蓓, 刘荣玉, 汪伟民, 孙昕, 赵卉, 庞玉瑛;实用医学杂志;20030725(第07期);719-721 *
髓过氧化物酶基因-463 G/A多态与中国人肺癌遗传易感性;吕文富, 齐军, 邢德印, 谭文, 缪小平, 苏蔚, 吴旻, 林东昕;中华肿瘤杂志;20020323(第03期);250-253 *

Also Published As

Publication number Publication date
KR101900016B1 (ko) 2018-09-20
AU2016228188B2 (en) 2018-01-04
JP6250600B2 (ja) 2017-12-20
EP2406401A4 (en) 2013-01-09
EP3257953B1 (en) 2018-09-26
CN108181457A (zh) 2018-06-19
WO2010105235A2 (en) 2010-09-16
KR20180104190A (ko) 2018-09-19
CN104535765A (zh) 2015-04-22
PL3257953T3 (pl) 2019-05-31
CA2755301C (en) 2019-01-08
KR20120010229A (ko) 2012-02-02
JP2022000650A (ja) 2022-01-04
JP6774925B2 (ja) 2020-10-28
JP2012520469A (ja) 2012-09-06
US11474104B2 (en) 2022-10-18
CA3024643A1 (en) 2010-09-16
AU2018202110B2 (en) 2020-09-03
WO2010105235A3 (en) 2011-02-24
JP2025114736A (ja) 2025-08-05
ES2703714T3 (es) 2019-03-12
CA3024643C (en) 2021-08-03
JP2019158890A (ja) 2019-09-19
KR102061441B1 (ko) 2019-12-31
JP2024024128A (ja) 2024-02-21
AU2010223911A1 (en) 2011-10-06
CN102405296A (zh) 2012-04-04
EP3444359A1 (en) 2019-02-20
EP3257953A1 (en) 2017-12-20
US20180356423A1 (en) 2018-12-13
CN113189342A (zh) 2021-07-30
JP2016006426A (ja) 2016-01-14
CA2755301A1 (en) 2010-09-16
JP2018072348A (ja) 2018-05-10
EP2857522A2 (en) 2015-04-08
EP2857522A3 (en) 2015-10-14
AU2016228188A1 (en) 2016-09-29
AU2018202110A1 (en) 2018-04-19
CN108181457B (zh) 2021-03-30
EP2406401A2 (en) 2012-01-18

Similar Documents

Publication Publication Date Title
CN113189342B (zh) 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒
US9933429B2 (en) Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
EP2781913B1 (en) Method for aiding in the diagnosis and therapy of asthma and lung cancer
WO2021076036A1 (en) Apparatuses and methods for detection of pancreatic cancer
KR101520615B1 (ko) 간암 진단용 바이오 마커
HK40058647A (en) Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
HK1202619B (en) Method for aiding in the diagnosis and therapy of asthma and lung cancer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40058647

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant